Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Wave Life Sciences stock

Own Wave Life Sciences stock in just a few minutes.

Wave Life Sciences Ltd is a biotechnology business based in the US. Wave Life Sciences shares (WVE) are listed on the NASDAQ and all prices are listed in US Dollars. Wave Life Sciences employs 217 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Wave Life Sciences

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – WVE – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Wave Life Sciences share price

Use our graph to track the performance of WVE stocks over time.

Wave Life Sciences shares at a glance

Information last updated 2021-03-10.
52-week range$6.61 - $19.98
50-day moving average $10.18
200-day moving average $9.79
Wall St. target price$16.57
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-5.15

Buy Wave Life Sciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Wave Life Sciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Wave Life Sciences financials

Revenue TTM $20.1 million
Gross profit TTM $-110,867,000
Return on assets TTM -34.02%
Return on equity TTM -184.78%
Profit margin 0%
Book value $1.70
Market capitalisation $453.2 million

TTM: trailing 12 months

Shorting Wave Life Sciences shares

There are currently 4.4 million Wave Life Sciences shares held short by investors – that's known as Wave Life Sciences's "short interest". This figure is 2.4% up from 4.3 million last month.

There are a few different ways that this level of interest in shorting Wave Life Sciences shares can be evaluated.

Wave Life Sciences's "short interest ratio" (SIR)

Wave Life Sciences's "short interest ratio" (SIR) is the quantity of Wave Life Sciences shares currently shorted divided by the average quantity of Wave Life Sciences shares traded daily (recently around 451271.26673532). Wave Life Sciences's SIR currently stands at 9.71. In other words for every 100,000 Wave Life Sciences shares traded daily on the market, roughly 9710 shares are currently held short.

However Wave Life Sciences's short interest can also be evaluated against the total number of Wave Life Sciences shares, or, against the total number of tradable Wave Life Sciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Wave Life Sciences's short interest could be expressed as 0.1% of the outstanding shares (for every 100,000 Wave Life Sciences shares in existence, roughly 100 shares are currently held short) or 0.1263% of the tradable shares (for every 100,000 tradable Wave Life Sciences shares, roughly 126 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Wave Life Sciences.

Find out more about how you can short Wave Life Sciences stock.

Wave Life Sciences share dividends

We're not expecting Wave Life Sciences to pay a dividend over the next 12 months.

Wave Life Sciences share price volatility

Over the last 12 months, Wave Life Sciences's shares have ranged in value from as little as $6.61 up to $19.98. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Wave Life Sciences's is 0.3738. This would suggest that Wave Life Sciences's shares are less volatile than average (for this exchange).

Wave Life Sciences overview

Wave Life Sciences Ltd. , a clinical stage genetic medicine company, designs, optimizes, and produces of novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. The company is primarily developing oligonucleotides that target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. It focuses on programs in neurology in the central nervous system and neuromuscular system. The company has a research, license, and option agreement with Pfizer Inc. and Takeda Pharmaceutical Company Limited for the research, development, and commercialization of stereopure oligonucleotide therapeutics and oligonucleotide therapeutics; and research, development, and develop antisense oligonucleotides. Wave Life Sciences Ltd.

Frequently asked questions

What percentage of Wave Life Sciences is owned by insiders or institutions?
Currently 12.967% of Wave Life Sciences shares are held by insiders and 76.712% by institutions.
How many people work for Wave Life Sciences?
Latest data suggests 217 work at Wave Life Sciences.
When does the fiscal year end for Wave Life Sciences?
Wave Life Sciences's fiscal year ends in December.
Where is Wave Life Sciences based?
Wave Life Sciences's address is: Marina One East Tower, Singapore, Singapore, 018936
What is Wave Life Sciences's ISIN number?
Wave Life Sciences's international securities identification number is: SG9999014716
What is Wave Life Sciences's CUSIP number?
Wave Life Sciences's Committee on Uniform Securities Identification Procedures number is: Y95308105

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site